This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Perey, L. Articles by Kufe, D. W. Search for Related Content PubMed PubMed Citation Articles by Perey, L. Articles by Kufe, D. W.

Tumor Selective Reactivity of a Monoclonal Antibody Prepared against a Recombinant Peptide Derived from the DF3 Human Breast Carcinoma-associated Antigen¹

Laboratory of Clinical Pharmacology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115 [L. P., D. F. H., P. M., M. A., D. W. K.], and Mallory Institute of Pathology, Boston University Medical Center, Boston, Massachusetts 02118 [C. O.]

The DF3 antigen is a member of a family of high molecular weight glycoproteins aberrantly expressed in malignant mammary epithelium. We have generated a monoclonal antibody (MAb), designated DF3-P, against a recombinant DF3/ß-galactosidase fusion protein. Characterization of this MAb has demonstrated reactivity with immature precursors of DF3 antigen and not with the secreted form. These findings are in contrast to those obtained with MAb DF3, a previously described antibody with predominant reactivity against the mature glycoprotein. The finding that deglycosylation of secreted DF3 antigen with neuraminidase and endo--N-acetylgalactosaminidase is associated with increased MAb DF3-P reactivity provided additional support for the selectivity of this antibody against the protein core. Epitope mapping studies demonstrate that both the DF3-P and DF3 epitopes are located at a TRPAPGS domain in the 20-amino acid tandem repeat. The results of competition studies with synthetic peptides indicate that the proline in this domain is involved in both epitopes, while the potential glycosylation sites at threonine and serine may contribute to the differential reactivity of MAbs DF3 and DF3-P. Taken together, these findings suggest that both antibodies react with a similar epitope that is modified by the presence of carbohydrate moieties. The results of immunoperoxidase staining studies further demonstrate that while MAb DF3-P reacts with formalin-fixed sections of breast carcinomas, this antibody exhibits little if any reactivity with normal mammary epithelium. Selective expression of the DF3-P epitope in malignant breast cells may be useful in identifying this transformed phenotype.

¹ This investigation was supported in part by la Ligue Vaudoise et la Ligue Suisse Contre le Cancer and la Fondation Muschamp, Lausanne, Switzerland (L. P.).

² To whom requests for reprints should be addressed, at 44 Binney Street, Boston, MA 02115.

Received 10/31/91. Accepted 2/26/92.

This article has been cited by other articles:

				B.-W. Park, J.-W. Oh, J.-H. Kim, S. H. Park, K.-S. Kim, J. H. Kim, and K. S. Lee Preoperative CA 15-3 and CEA serum levels as predictor for breast cancer outcomes Ann. Onc., April 1, 2008; 19(4): 675 - 681. [Abstract] [Full Text] [PDF]

				A Keshaviah, S Dellapasqua, N Rotmensz, J Lindtner, D Crivellari, J Collins, M Colleoni, B Thurlimann, C Mendiola, S Aebi, et al. CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials Ann. Onc., April 1, 2007; 18(4): 701 - 708. [Abstract] [Full Text] [PDF]

				J. Ren, D. Raina, W. Chen, G. Li, L. Huang, and D. Kufe MUC1 Oncoprotein Functions in Activation of Fibroblast Growth Factor Receptor Signaling Mol. Cancer Res., November 1, 2006; 4(11): 873 - 883. [Abstract] [Full Text] [PDF]

				K. Y. Tsang, C. Palena, J. Yokokawa, P. M. Arlen, J. L. Gulley, G. P. Mazzara, L. Gritz, A. Gomez Yafal, S. Ogueta, P. Greenhalgh, et al. Analyses of Recombinant Vaccinia and Fowlpox Vaccine Vectors Expressing Transgenes for Two Human Tumor Antigens and Three Human Costimulatory Molecules Clin. Cancer Res., February 15, 2005; 11(4): 1597 - 1607. [Abstract] [Full Text] [PDF]

				A. Moore, Z. Medarova, A. Potthast, and G. Dai In Vivo Targeting of Underglycosylated MUC-1 Tumor Antigen Using a Multimodal Imaging Probe Cancer Res., March 1, 2004; 64(5): 1821 - 1827. [Abstract] [Full Text] [PDF]

				R L Ten Berge, F G M Snijdewint, S von Mensdorff-Pouilly, R J J Poort-Keesom, J J Oudejans, J W R Meijer, R Willemze, J Hilgers, and C J L M Meijer MUC1 (EMA) is preferentially expressed by ALK positive anaplastic large cell lymphoma, in the normally glycosylated or only partly hypoglycosylated form J. Clin. Pathol., December 1, 2001; 54(12): 933 - 939. [Abstract] [Full Text] [PDF]

				C. Akewanlop, M. Watanabe, B. Singh, M. Walker, D. W. Kufe, and D. F. Hayes Phagocytosis of Breast Cancer Cells Mediated by Anti-MUC-1 Monoclonal Antibody, DF3, and Its Bispecific Antibody Cancer Res., May 1, 2001; 61(10): 4061 - 4065. [Abstract] [Full Text]

				S. P. Treon, J. A. Mollick, M. Urashima, G. Teoh, D. Chauhan, A. Ogata, N. Raje, J. H.M. Hilgers, L. Nadler, A. R. Belch, et al. Muc-1 Core Protein Is Expressed on Multiple Myeloma Cells and Is Induced by Dexamethasone Blood, February 15, 1999; 93(4): 1287 - 1298. [Abstract] [Full Text] [PDF]

				K. A. Foon, J. Yannelli, and M. Bhattacharya-Chatterjee Colorectal Cancer as a Model for Immunotherapy Clin. Cancer Res., February 1, 1999; 5(2): 225 - 236. [Full Text] [PDF]

				Y. Li, A. Bharti, D. Chen, J. Gong, and D. Kufe Interaction of Glycogen Synthase Kinase 3beta with the DF3/MUC1 Carcinoma-Associated Antigen and beta -Catenin Mol. Cell. Biol., December 1, 1998; 18(12): 7216 - 7224. [Abstract] [Full Text]

				J. Gong, D. Chen, M. Kashiwaba, Y. Li, L. Chen, H. Takeuchi, H. Qu, G. J. Rowse, S. J. Gendler, and D. Kufe Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells PNAS, May 26, 1998; 95(11): 6279 - 6283. [Abstract] [Full Text] [PDF]

				A. Bergeron, S. Champetier, Hélèn. LaRue, and Y. Fradet MAUB Is a New Mucin Antigen Associated with Bladder Cancer J. Biol. Chem., March 22, 1996; 271(12): 6933 - 6940. [Abstract] [Full Text] [PDF]

				Y. Li, H. Kuwahara, J. Ren, G. Wen, and D. Kufe The c-Src Tyrosine Kinase Regulates Signaling of the Human DF3/MUC1 Carcinoma-associated Antigen with GSK3beta and beta -Catenin J. Biol. Chem., February 23, 2001; 276(9): 6061 - 6064. [Abstract] [Full Text] [PDF]